GW Pharmaceuticals Ready to Accelerate Childhood Epilepsy Drug Development

Published February 5, 2014

GW Pharmaceuticals ready to accelerate childhood epilepsy drug development
Epidiolex has a US FDA orphan drug designation for the treatment of Dravet syndrome (a type of childhood epilepsy), and approval has been granted for a programme to treat 125 children. Treatment is now beginning in this programme, and initial data is … Read more on Proactive Investors UK

Drug treatment center eyes Greensburg opening
A Pittsburgh-based drug treatment program that dispenses Suboxone will open a facility in the Greensburg area within a few weeks, according to the company's CEO. Barney Seaton of Allied Addiction Recovery said his Pittsburgh-based operation is not a … Read more on Tribune-Review

Drug And Alcohol Treatment Centers – Why They Are Proven NOT to Work
drug and alcohol treatment centers http://truthofaddiction.com alcohol withdrawal treatment addiction recovery program outpatient alcohol treatment What if i…